The London-based clinical trials platform has secured $6m to date from high-profile investors.
"Clinical trials are the biggest bottleneck to improving human health. We’re working with high-growth companies developing the next wave of breakthrough treatments to accelerate the clinical trials process."
The funding round was co-led by Finch Capital and Outpost Ventures.
"Companies have to maintain countless technical integrations and vendor relationships, while reconciling global payments. At NomuPay, we remove the burden of ‘multiples’, by unifying fragmented payment networks. In the face of continued technological, market, method and data fragmentation, we provide companies with an ‘all access pass’ to global payments’, enabling enterprises to continue to expand globally, and to future-proof payment strategies."
The investment from the OnePlanetCapital Climate Change EIS Fund will support international expansion and product development.
"Impact is at the core of what we do at AirEx: to help the decarbonisation of homes and eliminate Fuel Poverty. With the help of this investment and business support we are well positioned to execute our vision – to become a ‘no brainer’ solution for social landlords and homeowners looking to reduce energy consumption in a non-disruptive way. We are truly excited to have the support of such like-minded, mission driven investors."
The London-based climate tech startup will use the capital to grow its team and scale platform capacity.
"We’re witnessing the dawn of a future multi-trillion dollar industry that has the potential to not only stop the climate catastrophe but also to drive scientific progress, and create jobs and opportunity around the world. As we embark on building the platform that will unlock that growth, I’m delighted we’ve already been able to attract some of the best talent from across the industry, and now we couldn’t be more pleased to have backers like GV and Capital T to support us on this journey."